SLC7A11 and ovarian carcinoma: Interestingly, the studies discussed in this review also showed that SLC7A11 expression can be downregulated by natural (agrimonolide, fructose and eriodictyol) and synthetic (olaparib, lidocaine and erastin) compounds (see Table 1), suggesting a potential use of these compounds in ovarian cancer treatment.